In a strategic move to refocus its pharmaceutical sector, Innobic (Asia) Co, the life sciences division of the PTT Plc national oil and gas conglomerate, has entirely divested its shares in Alvogen Malta (Out-licensing) Holding (AMOLH). The shares were acquired by Floki Holding Société à Responsibilité Limitée, a healthcare and pharmaceutical firm based in Luxembourg. The transaction is expected to be finalised within the first three months of the year.
AMOLH, a company dealing in the procurement and distribution of pharmaceutical products and licenses across various regions, most notably Europe, was held by Innobic through its subsidiary, Alvogen Emerging Markets Holdings.
Buranin Rattanasombat, chairman of Innobic (Asia), explained that this restructuring aims to streamline the company’s focus primarily on the Asia-Pacific region. Last…
